Literature DB >> 15510205

Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells.

M Bornhäuser, L Eger, U Oelschlaegel, S Auffermann-Gretzinger, A Kiani, J Schetelig, T Illmer, M Schaich, D Corbeil, C Thiede, G Ehninger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15510205     DOI： 10.1038/sj.leu.2403563

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

Authors:  E Mimiola; O Marini; O Perbellini; A Micheletti; W Vermi; S Lonardi; C Costantini; E Meneghelli; A Andreini; C Bonetto; A Vassanelli; M Cantini; E Zoratti; D Massi; A Zamo'; A Leso; G Quaresmini; F Benedetti; G Pizzolo; M A Cassatella; C Tecchio
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

2.  Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor.

Authors:  D Freund; J Oswald; S Feldmann; G Ehninger; D Corbeil; M Bornhäuser
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

3.  Proinflammatory human 6-sulfo LacNAc-positive dendritic cells accumulate in intestinal acute graft-versus-host disease.

Authors:  Ulrich Sommer; Brit Larsson; Sebastian Tuve; Rebekka Wehner; Nick Zimmermann; Michael Kramer; Anja Kloβ; Claudia Günther; Jana Babatz; Renate Schmelz; Stefan Brückner; Johannes Schetelig; Martin Bornhäuser; Knut Schäkel; Michael Philipp Bachmann; Daniela Aust; Gustavo Baretton; Marc Schmitz
Journal:  Haematologica       Date:  2014-03-28       Impact factor: 9.941

4.  Oxygen tension plays a critical role in the hematopoietic microenvironment in vitro.

Authors:  Duohui Jing; Manja Wobus; David M Poitz; Martin Bornhäuser; Gerhard Ehninger; Rainer Ordemann
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

5.  CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells.

Authors:  Kathrin Arndt; Tatyana Grinenko; Nicole Mende; Doreen Reichert; Melanie Portz; Tatsiana Ripich; Peter Carmeliet; Denis Corbeil; Claudia Waskow
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

6.  The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia.

Authors:  Jana Karbanová; Ewa Missol-Kolka; Ana-Violeta Fonseca; Christoph Lorra; Peggy Janich; Hana Hollerová; József Jászai; Jirí Ehrmann; Zdenek Kolár; Cornelia Liebers; Stefanie Arl; Danuse Subrtová; Daniel Freund; Jaroslav Mokry; Wieland B Huttner; Denis Corbeil
Journal:  J Histochem Cytochem       Date:  2008-07-21       Impact factor: 2.479

7.  Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics.

Authors:  Juana Serrano-Lopez; Shailaja Hegde; Sachin Kumar; Josefina Serrano; Jing Fang; Ashley M Wellendorf; Paul A Roche; Yamileth Rangel; Leolene J Carrington; Hartmut Geiger; H Leighton Grimes; Sanjiv Luther; Ivan Maillard; Joaquin Sanchez-Garcia; Daniel T Starczynowski; Jose A Cancelas
Journal:  Elife       Date:  2021-04-08       Impact factor: 8.713

8.  REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial.

Authors:  A King; D Barton; H A Beard; N Than; J Moore; C Corbett; J Thomas; K Guo; I Guha; D Hollyman; D Stocken; C Yap; R Fox; S J Forbes; P N Newsome
Journal:  BMJ Open       Date:  2015-03-20       Impact factor: 2.692

9.  Repopulating hematopoietic stem cells from steady-state blood before and after ex vivo culture are enriched in the CD34+CD133+CXCR4low fraction.

Authors:  Véronique Lapostolle; Jean Chevaleyre; Pascale Duchez; Laura Rodriguez; Marija Vlaski-Lafarge; Ioanna Sandvig; Philippe Brunet de la Grange; Zoran Ivanovic
Journal:  Haematologica       Date:  2018-06-01       Impact factor: 9.941

10.  Human responses against HER-2-positive cancer cells in human immune system-engrafted mice.

Authors:  C De Giovanni; G Nicoletti; L Landuzzi; F Romani; S Croci; A Palladini; A Murgo; A Antognoli; M L Ianzano; V Stivani; V Grosso; M Iezzi; L Stramucci; E Barbieri; R M Lemoli; P Nanni; P-L Lollini
Journal:  Br J Cancer       Date:  2012-08-28       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.